NO20005131D0 - Nye behandlinger for nervøse forstyrrelser - Google Patents

Nye behandlinger for nervøse forstyrrelser

Info

Publication number
NO20005131D0
NO20005131D0 NO20005131A NO20005131A NO20005131D0 NO 20005131 D0 NO20005131 D0 NO 20005131D0 NO 20005131 A NO20005131 A NO 20005131A NO 20005131 A NO20005131 A NO 20005131A NO 20005131 D0 NO20005131 D0 NO 20005131D0
Authority
NO
Norway
Prior art keywords
new treatments
nervous disorders
reboxetine
noradrenaline reuptake
new
Prior art date
Application number
NO20005131A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005131L (no
Inventor
Adriana Dubini
John Michael Mccall
Duncan Paul Taylor
Philip F Von Voigtlander
Erik Ho Fong Wong
Original Assignee
Pharmacia & Upjohn Spa
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa, Upjohn Co filed Critical Pharmacia & Upjohn Spa
Publication of NO20005131L publication Critical patent/NO20005131L/no
Publication of NO20005131D0 publication Critical patent/NO20005131D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Mobile Radio Communication Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20005131A 1998-04-13 2000-10-12 Nye behandlinger for nervøse forstyrrelser NO20005131D0 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8163298P 1998-04-13 1998-04-13
IT98MI000870 IT1305322B1 (it) 1998-04-23 1998-04-23 Uso di reboxetina per il trattamento di disturbi nervosi
US8503398P 1998-05-11 1998-05-11
PCT/US1999/004288 WO1999052518A2 (en) 1998-04-13 1999-04-02 New treatments for nervous disorders

Publications (2)

Publication Number Publication Date
NO20005131L NO20005131L (no) 2000-10-12
NO20005131D0 true NO20005131D0 (no) 2000-10-12

Family

ID=11379879

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005131A NO20005131D0 (no) 1998-04-13 2000-10-12 Nye behandlinger for nervøse forstyrrelser

Country Status (25)

Country Link
US (1) US6391876B1 (de)
EP (1) EP1071418B1 (de)
JP (1) JP2002511408A (de)
KR (1) KR100555279B1 (de)
CN (1) CN1197569C (de)
AT (1) ATE277617T1 (de)
AU (1) AU755612B2 (de)
BR (1) BR9909476A (de)
CA (1) CA2320722A1 (de)
DE (1) DE69920679T2 (de)
DK (1) DK1071418T3 (de)
EA (1) EA003546B1 (de)
ES (1) ES2228035T3 (de)
HU (1) HUP0101748A3 (de)
IL (1) IL138887A0 (de)
IT (1) IT1305322B1 (de)
NO (1) NO20005131D0 (de)
NZ (1) NZ507693A (de)
PL (1) PL194039B1 (de)
PT (1) PT1071418E (de)
SI (1) SI1071418T1 (de)
SK (1) SK14482000A3 (de)
TR (1) TR200002970T2 (de)
WO (1) WO1999052518A2 (de)
ZA (1) ZA200004480B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500827B2 (en) * 1998-05-08 2002-12-31 Pharmacia & Upjohn Company Drug combinations
ATE305788T1 (de) 1999-07-01 2005-10-15 Pharmacia & Upjohn Co Llc (s,s)-reboxetin zur behandlung von inkontinenz
SI1196172T1 (sl) * 1999-07-01 2006-06-30 Pharmacia & Upjohn Co Llc (S,S)-reboksetin za zdravljenje kronicne bolecine
EP1395253A2 (de) * 2000-11-15 2004-03-10 Eli Lilly And Company Behandlung von angstzuständen
PL375211A1 (en) * 2002-06-17 2005-11-28 Pharmacia Italia S.P.A. Pharmaceutical salts of reboxetine
US20100069389A1 (en) * 2008-09-06 2010-03-18 Bionevia Pharmaceuticals, Inc. Novel forms of reboxetine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL56369A (en) 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
GB8419683D0 (en) 1984-08-02 1984-09-05 Erba Farmitalia 3-substituted derivatives of 1-amino-2-hydroxy-propane
GB2167407B (en) * 1984-11-22 1988-05-11 Erba Farmitalia Enantiomers of phenoxy derivatives of benzyl morpholine and salts thereof
WO1999020279A1 (en) * 1997-10-17 1999-04-29 Eli Lilly And Company Potentiation of pharmaceuticals

Also Published As

Publication number Publication date
EA003546B1 (ru) 2003-06-26
CN1197569C (zh) 2005-04-20
ZA200004480B (en) 2002-04-24
AU755612B2 (en) 2002-12-19
US6391876B1 (en) 2002-05-21
PL346294A1 (en) 2002-01-28
EP1071418B1 (de) 2004-09-29
NO20005131L (no) 2000-10-12
DK1071418T3 (da) 2005-01-03
SK14482000A3 (sk) 2001-08-06
SI1071418T1 (en) 2005-04-30
HUP0101748A3 (en) 2001-12-28
KR100555279B1 (ko) 2006-03-03
DE69920679D1 (de) 2004-11-04
BR9909476A (pt) 2000-12-19
WO1999052518A3 (en) 1999-12-02
CA2320722A1 (en) 1999-10-21
PL194039B1 (pl) 2007-04-30
ITMI980870A1 (it) 1999-10-23
HUP0101748A2 (hu) 2001-11-28
IT1305322B1 (it) 2001-05-04
EP1071418A2 (de) 2001-01-31
TR200002970T2 (tr) 2001-01-22
JP2002511408A (ja) 2002-04-16
ES2228035T3 (es) 2005-04-01
IL138887A0 (en) 2001-11-25
NZ507693A (en) 2003-08-29
EA200001058A1 (ru) 2001-04-23
PT1071418E (pt) 2004-12-31
ATE277617T1 (de) 2004-10-15
AU3635199A (en) 1999-11-01
DE69920679T2 (de) 2006-03-02
CN1293569A (zh) 2001-05-02
KR20010042641A (ko) 2001-05-25
WO1999052518A2 (en) 1999-10-21

Similar Documents

Publication Publication Date Title
DK1071418T3 (da) Nye behandlinger til nervelidelser
BRPI0407256A (pt) Utilização do enantiÈmero (1s,2r) do milnacipran para a preparação de um medicamento
MY134110A (en) Combinations of reboxetine and neuroleptic agents
DE50313386D1 (de) Mittelwalze eines Kalanders mit einer Tilgeranordnung
PT721777E (pt) Utilizacao de tomoxetina para o tratamento do disturbio de deficit de atencao/hiperactividade
EE200100441A (et) Monoamiinide taasomastamise inhibiitorid kesknärvisüsteemi haiguste raviks
DE602004031893D1 (de) Verwendung des Enantiomers (1S, 2R) von Milnacipran zur Herstellung eines Arzneimittels
NO20021035D0 (no) Fremgangsmåter for anvendelse av rasktvirkende selektive serotonin gjenopptakningsinhibitorer for behandling av seksuelldysfunksjon
AR058239A1 (es) Metodos para tratar trastornos de ansiedad
AR021155A1 (es) Tratamiento de desordenes neuroticos
WO2002077198A8 (en) Methods of modulating angiogenesis
DK1626720T3 (da) 4-(2-Phenylsulfanyl-phenyl)-piperidinderivater som serotonin-genoptagelseshæmmer
NO20070914L (no) Fremgangsmater for behandling av nervesystemforstyrrelser og tilstander
PT1075264E (pt) Novas combinacoes farmacologicas de reboxetina e pindolol
WO2002040006A3 (en) Treatment of anxiety disorders
EA200400793A1 (ru) Применение ингибиторов обратного захвата норэпинефрина для лечения нарушения познавательной функции
CO4950552A1 (es) Nueva composicion lectivos de la reabsorcion de seotonina y un bloqueador b
PT1077935E (pt) Fenilsulfonamida-feniletilaminas uteis como receptores da dopamina
PT1054671E (pt) Nova utilizacao da ropivacaina para o controlo da dor
BR9915712A (pt) Usos de ciclobutilalquilaminas substituìdas com arila, e da sibutramina e seus enanciÈmeros e seus sais farmaceuticamente apropriados, e, método para o tratamento da incontinência urinária
ZA991638B (en) Method of treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders and autism.
DE50115630D1 (de) Katalysator für die hydrierung von ungesättigten kohlenwasserstoffen
EA200600183A1 (ru) Сочетание ингибитора обратного захвата серотонина и агомелатина

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application